Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition

AMERICAN JOURNAL OF HEMATOLOGY

Simara, P; Stejskal, S; Koutna, I; Potesil, D; Tesarova, L; Potesilova, M; Zdrahal, Z; Mayer, J, 2013: Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition. AMERICAN JOURNAL OF HEMATOLOGY 88(5), p. 385 - 393, doi: 10.1002/ajh.23419

Research Groups:

Proteomics Core Facility
Proteomics

CEITEC authors:

Prof. Zbyněk Zdráhal
Prof. Jiří Mayer